Skip to content
DataLookout
Menu

COOLINGNCT06109376

Role of Hypothermia in Endovascular Stroke Thrombectomy

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment reduced: 200 → 100 participants Show 5 more changesShow less
    • Recruitment opened
    • Eligibility criteria expanded, about 33 words
    • Study completion moved earlier from Mar 31, 2027 to Dec 31, 2026
    • Study sites: 0 to 2
    • Secondary endpoints revised (15)
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Modified Rankin scale score (mRS)
Timeframe: 90 days post-randomization

Secondary (15)

Excellent outcome
Functional independence
Moderate outcome
Early neurological improvement
NIHSS score at 5 to 7 days or discharge
Show 10 moreShow less
Successful reperfusion at final angiogram
Difference between baseline and within 48h after procedure of infarction core volume (ml)
Reperfusion on follow-up CT or MR angiography
Incidence of symptomatic intracranial hemorrhage (SICH)
incidence of any intracranial hemorrhage (any ICH)
90-day mortality
Difference of hematocrit between baseline and 24-hour post-randomization
Non-hemorrhagic serious adverse event rate
Complications related to operation and device
Other serious adverse events

Arms and interventions

HypothermiaExperimental

Patients in Hypothermia group received hypothermia combined with endovascular thrombectomy.

ControlActive comparator

Patients in Control group received endovascular thrombectomy alone.

Procedures: hypothermia, thrombectomy

Sites

2 sites in 1 country